Agentic AI Comparison:
Isomorphic Labs vs Kosmos
vs
Introduction
This report compares Kosmos (as described in the Edison Scientific ecosystem and related research repos) and Isomorphic Labs (the Alphabet/DeepMind‑founded AI drug discovery company) across five practical metrics: autonomy, ease of use, flexibility, cost, and popularity. Scores run from 1–10, with higher values indicating better performance relative to the other agent in this pairwise comparison.
Overview
Isomorphic Labs
Isomorphic Labs is an Alphabet company founded by Google DeepMind CEO Demis Hassabis to reimagine drug discovery using AI, leveraging a state-of-the-art drug design engine built on Google Cloud with NVIDIA GPUs and deeply integrated into industrial drug discovery workflows.
Kosmos
Kosmos, in the Edison Scientific context, is positioned as a research‑oriented AI/agent platform and associated tooling, emerging from academic-style work (e.g., arXiv publication and open GitHub code) and a vertical platform at Edison Scientific. It is oriented toward experimentation, multimodal research, and programmable agentic workflows rather than being a large, closed, commercial organization.
Metrics Comparison
autonomy
Isomorphic Labs: 9
Isomorphic Labs operates a production-grade AI drug design engine on Google Cloud with NVIDIA GPUs, working on end-to-end drug discovery tasks in collaboration with pharmaceutical partners; its systems embody highly automated workflows for molecular design, evaluation, and prioritization, demonstrating a high degree of practical autonomy in a focused domain.
Kosmos: 7
Kosmos, as a research and platform ecosystem, is designed for agentic and multimodal workflows, and the Edison Scientific platform emphasizes AI agents that can perform multi-step reasoning and integration with scientific data sources; however, as an emerging research‑centric tool, its autonomy is constrained by limited production-scale deployments and stronger dependence on user orchestration.
Both agents employ advanced AI and automation, but Isomorphic Labs exhibits higher, domain-specific operational autonomy in drug discovery, while Kosmos favors flexible, programmable autonomy at a more research/prototyping layer.
ease of use
Isomorphic Labs: 6
Isomorphic Labs builds powerful internal tools and pipelines for drug discovery, but these are targeted at expert users such as computational chemists and biopharma partners rather than general developers or lay users; its interfaces are optimized for specialized workflows rather than broad ease of use.
Kosmos: 7
Kosmos appears as a developer- and researcher-facing platform, with open-source code and a dedicated Edison Scientific platform, which generally improves accessibility for technical users but still assumes comfort with APIs, configuration, and possibly research workflows, making it less turnkey for non-technical end-users.
For general developers and researchers, Kosmos is likely easier to access and experiment with via open and platform-based tooling, whereas Isomorphic Labs provides highly specialized but less broadly accessible tools for expert drug discovery teams.
flexibility
Isomorphic Labs: 6
Isomorphic Labs focuses its AI stack on drug discovery, using a highly optimized engine for molecular design and related tasks; while the underlying models and infrastructure are powerful, the deployed system is tightly tailored to pharmaceutical R&D workflows rather than general-purpose AI use.
Kosmos: 8
Kosmos, as a research and open-source oriented system, is adaptable to a variety of multimodal and agentic experiments, allowing users to repurpose components for different scientific or general AI tasks, and is less locked into a single domain or commercial workflow.
Kosmos offers greater flexibility across use cases due to its open, research platform nature, whereas Isomorphic Labs prioritizes depth and optimization in the single high-value domain of drug discovery.
cost
Isomorphic Labs: 4
Isomorphic Labs operates on Google Cloud with NVIDIA GPUs and focuses on large-scale drug discovery projects with pharma partners, implying high infrastructure and collaboration costs; access is oriented toward major industrial R&D programs rather than low-cost, self-serve usage.
Kosmos: 8
Kosmos provides open-source components and a research‑oriented platform, which typically reduces entry cost for experimentation; users can deploy on commodity cloud or local hardware, making marginal experimentation relatively inexpensive compared with commercial, closed enterprise offerings, though at-scale deployments still incur usual compute costs.
For independent researchers or smaller teams, Kosmos is substantially more cost-accessible, while Isomorphic Labs targets high-budget, enterprise-level drug discovery efforts with correspondingly higher cost structures.
popularity
Isomorphic Labs: 9
Isomorphic Labs benefits from being an Alphabet company founded by Demis Hassabis, frequently covered in AI and biotech news, and highlighted alongside Google DeepMind and NVIDIA in public announcements; its brand recognition and visibility in AI-driven drug discovery are correspondingly high.
Kosmos: 5
Kosmos, as a newer research/platform project with an arXiv paper and GitHub presence, has visibility within specific technical and academic communities but does not have large-scale mainstream or industry-wide brand recognition compared with major AI or biotech companies.
Kosmos is known primarily in narrower technical circles, whereas Isomorphic Labs has global visibility due to its association with Alphabet, DeepMind, and high-profile AI drug discovery announcements.
Conclusions
Kosmos and Isomorphic Labs represent two very different types of AI agents: Kosmos as a research- and developer-centric, relatively open and flexible platform, and Isomorphic Labs as a highly focused, industrial-scale AI engine for drug discovery embedded within Alphabet’s ecosystem. In this comparison, Isomorphic Labs scores higher on autonomy and popularity due to its production drug design engine and strong corporate backing, while Kosmos scores higher on flexibility and cost thanks to its open, research-oriented architecture and lower barriers to experimentation. Ease of use is mixed: Kosmos is more approachable for general technical users, whereas Isomorphic Labs offers polished but specialized tools for expert drug discovery teams.